These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 21756200

  • 21. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D, Watelle M, Van der Flaes M, Nolard N.
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [Abstract] [Full Text] [Related]

  • 22. [Susceptibility of Candida albicans blood isolates to 3 antifungal drugs: retrospective study in Rio Grande do Sul, Brazil, 1999-2009].
    Mattei AS, Alves SH, Mario DA, Watte G, Severo CB, Guazzelli Lda S, Oliveira Fde M, Severo LC.
    Rev Iberoam Micol; 2013 Jun; 30(4):243-7. PubMed ID: 23500157
    [Abstract] [Full Text] [Related]

  • 23. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synergistic Interaction of Certain Essential Oils and Their Active Compounds with Fluconazole against Azole-resistant Strains of Cryptococcus neoformans.
    Khan MSA.
    Ann Afr Med; 2024 Jul 01; 23(3):391-399. PubMed ID: 39034564
    [Abstract] [Full Text] [Related]

  • 26. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G.
    J Antimicrob Chemother; 1998 Jan 01; 41(1):59-65. PubMed ID: 9511038
    [Abstract] [Full Text] [Related]

  • 27. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Cordeiro RA, Teixeira CE, Brilhante RS, Castelo-Branco DS, Paiva MA, Giffoni Leite JJ, Lima DT, Monteiro AJ, Sidrim JJ, Rocha MF.
    Med Mycol; 2013 Jan 01; 51(1):53-9. PubMed ID: 22712455
    [Abstract] [Full Text] [Related]

  • 28. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec 01; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 29. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S, Keçeli Özcan S, Cınar S, Corakçı A, Calışkan E.
    Mikrobiyol Bul; 2011 Oct 01; 45(4):697-706. PubMed ID: 22090300
    [Abstract] [Full Text] [Related]

  • 30. Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.
    Khan MS, Ahmad I.
    Appl Microbiol Biotechnol; 2011 May 01; 90(3):1083-94. PubMed ID: 21336686
    [Abstract] [Full Text] [Related]

  • 31. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.
    Int J Antimicrob Agents; 2005 Apr 01; 25(4):321-8. PubMed ID: 15784312
    [Abstract] [Full Text] [Related]

  • 32. Antifungal activity of Coriandrum sativum essential oil, its mode of action against Candida species and potential synergism with amphotericin B.
    Silva F, Ferreira S, Duarte A, Mendonça DI, Domingues FC.
    Phytomedicine; 2011 Dec 15; 19(1):42-7. PubMed ID: 21788125
    [Abstract] [Full Text] [Related]

  • 33. In vitro synergistic efficacy of combination of amphotericin B with Myrtus communis essential oil against clinical isolates of Candida albicans.
    Mahboubi M, Ghazian Bidgoli F.
    Phytomedicine; 2010 Aug 15; 17(10):771-4. PubMed ID: 20189786
    [Abstract] [Full Text] [Related]

  • 34. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
    Mallié M, Bastide JM.
    Drugs Exp Clin Res; 1996 Aug 15; 22(6):301-7. PubMed ID: 9034756
    [Abstract] [Full Text] [Related]

  • 35. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
    Bulik CC, Sobel JD, Nailor MD.
    Mycoses; 2011 Jan 15; 54(1):34-8. PubMed ID: 19563489
    [Abstract] [Full Text] [Related]

  • 36. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
    Li XC, Jacob MR, ElSohly HN, Nagle DG, Smillie TJ, Walker LA, Clark AM.
    J Nat Prod; 2003 Aug 15; 66(8):1132-5. PubMed ID: 12932143
    [Abstract] [Full Text] [Related]

  • 37. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV, Pavliuk TD.
    Mikrobiol Z; 2003 Aug 15; 65(5):26-9. PubMed ID: 14723159
    [Abstract] [Full Text] [Related]

  • 38. The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance.
    Kolaczkowska A, Kolaczkowski M, Sokolowska A, Miecznikowska H, Kubiak A, Rolka K, Polanowski A.
    Mycoses; 2010 Jul 15; 53(4):314-20. PubMed ID: 19549107
    [Abstract] [Full Text] [Related]

  • 39. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P.
    J Antimicrob Chemother; 2004 Mar 15; 53(3):526-9. PubMed ID: 14963064
    [Abstract] [Full Text] [Related]

  • 40. Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans.
    Sharifzadeh A, Khosravi AR, Shokri H, Sharafi G.
    J Mycol Med; 2015 Jun 15; 25(2):143-50. PubMed ID: 25982599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.